Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1018]
News [2103]
Articles [147]
Editorials [11]
Conferences [147]
elearning [29]
U.S. National Cancer Institute perspective on precision oncology
Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA
U.S. National Cancer Institute perspective on precision oncology ( Dr James Doroshow - National Cancer Institute, NIH, Bethesda, USA )
6 Jul 2018
Early development in oncology: Are the MTD and monotherapy efficacy still the...
Dr Giorgio Massimini - Merck KGaA, Germany
Early development in oncology: Are the MTD and monotherapy efficacy still the best objectives? ( Dr Giorgio Massimini - Merck KGaA, Germany )
6 Jul 2018
Lessons from long-term survey of stage I NSCLC
Prof Harvey Pass - New York University Langone Medical Center, New York, USA
Lessons from long-term survey of stage I NSCLC ( Prof Harvey Pass - New York University Langone Medical Center, New York, USA )
6 Jul 2018
Implementing precision medicine in oncology: The IMPACT trials
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Implementing precision medicine in oncology: The IMPACT trials ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
6 Jul 2018
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
Treating CLL with obinutuzumab
Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Treating CLL with obinutuzumab ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
17 Jun 2018
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018
Improved OS with obinutuzumab in the CLL11 study
Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018
Update on bb2121 for relapsed myeloma
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018
International cancer control plans
Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )
4 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation